G16B 15/00
Ict specially adapted for analysing two-dimensional [2d] or three-dimensional [3d] molecular structures
Official title: ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
G16B15/00 (Ict specially adapted for analysing two-dimensional [2d] or three-dimensional [3d] molecular structures) appears on 1,125 US grants and 2,863 published applications in this corpus.
Search patents in G16B- Granted patents
- 1,125
- Published applications
- 2,863
- Assignees
- 1,135
- Inventors
- 6,143
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 6 | 0 |
| 1997 | 9 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 7 | 0 |
| 2001 | 15 | 10 |
| 2002 | 10 | 63 |
| 2003 | 12 | 98 |
| 2004 | 15 | 85 |
| 2005 | 18 | 88 |
| 2006 | 20 | 86 |
| 2007 | 26 | 84 |
| 2008 | 23 | 82 |
| 2009 | 22 | 76 |
| 2010 | 42 | 70 |
| 2011 | 51 | 88 |
| 2012 | 46 | 61 |
| 2013 | 50 | 73 |
| 2014 | 37 | 71 |
| 2015 | 38 | 69 |
| 2016 | 33 | 73 |
| 2017 | 37 | 62 |
| 2018 | 47 | 75 |
| 2019 | 56 | 130 |
| 2020 | 37 | 110 |
| 2021 | 44 | 138 |
| 2022 | 77 | 196 |
| 2023 | 81 | 224 |
| 2024 | 70 | 223 |
| 2025 | 91 | 313 |
| 2026 | 75 | 215 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Analyte characterization via iterative analysis6 Oct 2026US 12,754,188 B2Nautilus Subsidiary, Inc.
- Maintaining hierarchical representation of a protein complex6 Oct 2026US 12,755,811 B1Benchling, Inc.
- Optimization of genetic sequences6 Oct 2026US 12,755,812 B1Nanil Therapeutics Inc.
- Machine learning enabled prediction of molecular structures and properties29 Sep 2026US 12,749,554 B2Genentech, Inc.
- Multipole moment based coarse grained representation of antibody electrostatics29 Sep 2026US 12,749,555 B2Genentech, Inc.
- Methods and systems for detecting genetic variants8 Oct 2026US 2026/0308677 A1Guardant Health, Inc.
- Systems and Methods For The Identification And Characterization Of Pathogens In Urine Samples To Inform Patient Treatment8 Oct 2026US 2026/0308700 A1Biotia, Inc.
- Clearance prediction according to antibody property analysis8 Oct 2026US 2026/0311799 A1
- Programmable e3 ligase identification8 Oct 2026US 2026/0311800 A1Monte Rosa Therapeutics AG
- System and method for determining candidate rna binders8 Oct 2026US 2026/0311801 A1Ladder Therapeutics, Inc.
Most cited
By later US patents
- Modified antibody variable domains462US 5,766,886 AXoma Corporation · 1998
- Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides341US 4,704,692 A1987
- Bioinformatically detectable group of novel regulatory genes and uses thereof215US 7,250,496 B2Rosetta Genomics Ltd. · 2007
- System and method of automatically generating chemical compounds with desired properties209US 5,463,564 A3-Dimensional Pharmaceuticals, Inc. · 1995
- Methods for identifying sets of oligonucleotides for use in an in vitro recombination procedure185US 7,620,502 B2Maxygen, Inc. · 2009